首页> 美国卫生研究院文献>Therapeutic Advances in Drug Safety >Curse of the ghost pills: the role of oral controlled-release formulations in the passage of empty intact shells in faeces. Two case reports and a literature review relevant to psychiatry
【2h】

Curse of the ghost pills: the role of oral controlled-release formulations in the passage of empty intact shells in faeces. Two case reports and a literature review relevant to psychiatry

机译:鬼药的诅咒:口服控释制剂在粪便中空的完整外壳通过中的作用。有关精神病学的两个病例报告和文献复习

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Orally taken tablets in different formulations continue to have a central role in the treatment of various psychiatric and medical conditions. In order to improve compliance, reduce the frequency of taking medications and minimize the peaks and troughs associated with certain immediate-release formulations, pharmaceutical companies have developed a number of novel methods of delivering oral solid dosage medications in the form of controlled-release (CR) formulations. Some CR formulations have been associated with pharmacobezoars and false-positive findings on certain physical investigations. Though CR drugs are commonly used in psychiatry, clinicians appear to have a limited understanding of how they are released for absorption once ingested. Some have insoluble parts that are excreted in faeces as ‘ghost pills’. Due to lack of awareness of this phenomenon to both patients and the physicians, anxiety has ensued in some patients. Some clinicians have been puzzled or have been dismissive when faced with curious patients wanting to know more after they had observed tablet-like looking structures in faeces. We present two cases from our clinical setting and a few drawn from the World Wide Web to highlight the role of CR medications and their association with the ghost pill phenomenon. The mechanisms involved in drug release relevant to psychiatry medications are also briefly reviewed. The ghost pill phenomenon occurs with certain CR medications. This is a normal and expected outcome related to drug-release mechanisms of some of these products. It is inevitable that some patients will see what looks like tablets or capsules in faeces. Raising awareness of this phenomenon among clinicians would facilitate discussions and information sharing at the initial process of medication prescribing. Awareness among patients and carers would also help to allay anxiety.
机译:不同制剂的口服片剂在各种精神病和医学疾病的治疗中继续发挥核心作用。为了提高依从性,减少服药的频率并使与某些即释制剂相关的峰谷最小化,制药公司已经开发出许多新颖的方法以控释(CR)形式口服固体制剂)配方。在某些物理研究中,某些CR配方与药牛和假阳性结果有关。尽管CR药物通常用于精神病学,但临床医生似乎对摄入后如何释放以吸收吸收了解有限。有些具有不溶性成分,会作为“鬼药”排泄在粪便中。由于患者和医师都缺乏对这种现象的认识,因此在一些患者中产生了焦虑。当面对好奇的病人,他们在粪便中观察到类似药片的外观结构后,想了解更多信息时,有些临床医生感到困惑或不屑一顾。我们从临床环境中介绍了两个案例,并从万维网中摘录了一些案例,以强调CR药物的作用及其与鬼丸现象的关联。还简要回顾了与精神病药物有关的药物释放机制。某些CR药物会引起幻影现象。这是与这些产品中某些药物释放机制有关的正常和预期结果。不可避免的是,有些患者会在粪便中看到片剂或胶囊状的东西。在临床医生中提高对这种现象的认识将有助于在开药的最初过程中进行讨论和信息共享。患者和护理人员之间的意识意识也将有助于减轻焦虑。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号